EVECXIA THERAPEUTICS
Evecxia Therapeutics is a privately funded, clinical-stage pharmaceutical company that is dedicated to realizing the therapeutic potential of 5-hydroxytryptophan. It aims to develop and commercialize EVX-101, to treat patients suffering from disabling, common, and costly neuropsychiatric conditions in which current therapies are inadequate, in particular depression. The company was established in 2013 and is based in Raleigh, North Carolina.
EVECXIA THERAPEUTICS
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.evecxia.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15.12 M USD
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.evecxia.com
- Host name: ec2-18-222-195-17.us-east-2.compute.amazonaws.com
- IP address: 18.222.195.17
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
